<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00622167</url>
  </required_header>
  <id_info>
    <org_study_id>2007P001842</org_study_id>
    <nct_id>NCT00622167</nct_id>
  </id_info>
  <brief_title>Comparison of DSCT With IB-IVUS and Angiography in the Assessment of Coronary Artery Disease</brief_title>
  <official_title>Comparison of Dual Source Computed Tomography (DSCT) With Integrated Backscatter Intravascular Ultrasound (IB-IVUS) and Contrast Angiography in the Assessment of Coronary Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare different methods of looking at atherosclerotic
      plaques in heart arteries. Identifying the characteristics of these plaques noninvasively
      would be very valuable. This study is looking at a new CT scanner (DSCT) to noninvasively
      image these plaques compared to invasive ultrasound (the current standard).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objectives of this study are:

        1. To compare with contrast angiography, the ability of DSCT to detect and quantify
           coronary artery stenoses.

        2. To compare with gray-scale IVUS, the ability of DSCT to quantify plaque cross-sectional
           diameter &amp; area measurements &amp; plaque volume.

        3. To evaluate the ability of DSCT to assess plaque morphology and quantify plaque
           components as compared to gray-scale and IB-IVUS.

        4. To evaluate the ability of DSCT to identify &amp; measure lesion remodeling compared to
           gray-scale IVUS.

        5. To determine if pre-PCI evaluation of coronary plaque morphology by IB-IVUS can a)
           predict procedural success as assessed by adequate stent strut apposition and expansion
           and b) peri-procedural myocardial necrosis as measured by biomarker elevation.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Subject recruitment was slow, so enrollment has been closed.
  </why_stopped>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of Plaque Characteristics Between DSCT (Dual Source Computed Tomography) and IVUS (Intravascular Ultrasound).</measure>
    <time_frame>At time of imaging</time_frame>
    <description>Characteristics include plaque cross-sectional diameter, area measurements, plaque volume, and plaque morphology (composition).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All patients will receive integrated backscatter IVUS and dual source CT.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Integrated Backscatter IVUS</intervention_name>
    <description>All subjects have Integrated Backscatter IVUS and Dual Source CT imaging.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dual Source Computed Tomography</intervention_name>
    <description>All subjects have DSCT and IBIVUS imaging</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or non-pregnant females

          -  &gt; / = 18 years of age

          -  Scheduled for coronary angiography

        Exclusion Criteria:

          -  Acute ST-elevation myocardial infarction within last 72 hours

          -  Current congestive heart failure

          -  Current cardiogenic shock

          -  Unstable clinical condition

          -  Known cardiomyopathy (EF &lt; 30%)

          -  Creatinine &gt;1.5 mg/dL

          -  Definite allergy to iodinated contrast media

          -  Current participation in an investigational drug or device research study

          -  HR &gt; 65 and contraindications to the administration of beta blockers

        Exclusion criteria assessed during catheterization procedure

          -  PCI of native coronary vessel not performed

          -  Left main stenosis &gt; 50%

          -  Any vessel contraindicated for IVUS imaging

          -  Any lesion contraindicated for IVUS imaging

          -  Inability to pass IVUS catheter

          -  PCI of bifurcation lesion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ik-Kyung Jang, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2008</study_first_submitted>
  <study_first_submitted_qc>February 21, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 22, 2008</study_first_posted>
  <results_first_submitted>July 28, 2011</results_first_submitted>
  <results_first_submitted_qc>January 3, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 3, 2012</results_first_posted>
  <last_update_submitted>January 3, 2012</last_update_submitted>
  <last_update_submitted_qc>January 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Ik-Kyung Jang, MD, PhD</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Plaque characteristics</keyword>
  <keyword>DSCT</keyword>
  <keyword>IVUS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were enrolled from January 2008 until September 2008. The study ended early due to slow enrollment.</recruitment_details>
      <pre_assignment_details>Subjects were consented prior to cardiac catheterization, and if they did not meet angiographic inclusion criteria they were withdrawn from the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>IBIVUS and DSCT</title>
          <description>All patients will receive integrated backscatter IVUS and dual source CT.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Did not meet angiographic criteria</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>IBIVUS and DSCT</title>
          <description>All patients will receive integrated backscatter IVUS and dual source CT.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="24"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">Study terminated after imaging 4 subjects due to slow enrollment. No analysis performed.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Comparison of Plaque Characteristics Between DSCT (Dual Source Computed Tomography) and IVUS (Intravascular Ultrasound).</title>
        <description>Characteristics include plaque cross-sectional diameter, area measurements, plaque volume, and plaque morphology (composition).</description>
        <time_frame>At time of imaging</time_frame>
        <population>Imaging 30 subjects was predicted to include enough plaques for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Plaque Characteristics</title>
            <description>Characteristics include plaque cross-sectional diameter, area measurements, plaque volume, and plaque morphology.</description>
          </group>
        </group_list>
        <measure>
          <title>Comparison of Plaque Characteristics Between DSCT (Dual Source Computed Tomography) and IVUS (Intravascular Ultrasound).</title>
          <description>Characteristics include plaque cross-sectional diameter, area measurements, plaque volume, and plaque morphology (composition).</description>
          <population>Imaging 30 subjects was predicted to include enough plaques for analysis.</population>
          <units>plaques</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Plaques</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Plaque characteristics including plaque cross-sectional diameter, area measurements, plaque volume, and plaque morphology would be compared between IBIVUS, DSCT and angiography.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0</p_value>
            <method>Not done</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Total number of subjects at risk=4 since 20 subjects were screen failures and did not have any study imaging.</desc>
      <group_list>
        <group group_id="E1">
          <title>IBIVUS and DSCT</title>
          <description>All patients will receive integrated backscatter IVUS and dual source CT.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Study terminated after imaging 4 subjects due to slow enrollment. Results will not be analyzed.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Iris McNulty, RN</name_or_title>
      <organization>Massachusetts General Hospital</organization>
      <phone>617 726 2612</phone>
      <email>imcnulty@partners.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

